Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro (Q42287587)
Jump to navigation
Jump to search
scientific article published on January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro |
scientific article published on January 1994 |
Statements
1 reference
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro (English)
1 reference
Lin TS
1 reference
Luo MZ
1 reference
Liu MC
1 reference
Pai SB
1 reference
Dutschman GE
1 reference
Cheng YC
1 reference
1 January 1994
1 reference
1 reference